Motif Neurotech is a Neuromodulation & Stimulation company founded in 2020 and based in Houston, United States. It has raised $18.8M in total funding, most recently a Series A in 2024.

An analysis piece finds that BCI startups' use of 'minimally invasive' is fuzzy and inconsistent.
A pea-sized (~9 mm) minimally-invasive cortical neurostimulator implanted via a brief outpatient procedure to treat treatment-resistant depression. Pairs wirelessly with a wearable hat that delivers prescribed stimulation sessions at home. Uses magnetoelectric energy transfer derived from Rice University IP, avoiding the large external magnets required by TMS while targeting specific cortical regions.
An investigational deep-brain modulation implant targeting subcortical structures associated with mood regulation, developed under FDA Investigational Device Exemption for treatment-resistant depression. Designed to deliver closed-loop electrical stimulation with sensing capabilities to personalize therapy based on detected neural biomarkers.